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Abstract
Background: Recently, dipeptide aureusimines were reported to activate expression of staphylococcal virulence genes, such
as alpha-hemolysin, and increase S. aureus virulence. Surprisingly, most of the virulence genes affected by aureusimines
form part of the regulon of the SaeRS two component system (TCS), raising the possibility that SaeRS might be directly or
indirectly involved in the aureusimine-dependent signaling process.
Methodology/Principal Findings: Using HPLC analyses, we confirmed that a transposon mutant of ausA, the gene
encoding the aureusimine dipeptide synthesis enzyme, does not produce dipeptides. However, the transposon mutant
showed normal hemolysis activity and alpha-hemolysin/SaeP production. Furthermore, the P1 promoter of the sae operon,
one of the targets of the SaeRS TCS, showed normal transcription activity. Moreover, in contrast to the original report, the
ausA transposon mutant did not exhibit attenuated virulence in an animal infection model. DNA sequencing revealed that
the ausA deletion mutant used in the original study has an 83 nt-duplication in saeS. Hemolysis activity of the original
mutant was restored by a plasmid carrying the sae operon. A mutant of the sae operon showed elevated resistance to
chloramphenicol and erythromycin, two antibiotics widely used during staphylococcal mutagenesis. At 43uC in the presence
of erythromycin and aeration, the conditions typically employed for staphylococcal mutagenesis, an saeR transposon
mutant grew much faster than a control mutant and the saeR mutant was highly enriched in a mixed culture experiment.
Conclusions/Significance: Our results show that the previously reported roles of aureusimines in staphylococcal gene
regulation and virulence were due to an unintended mutation in saeS, which was likely selected due to elevated resistance
of the mutant to environmental stresses. Thus, there is no evidence indicating that the dipeptide aureusimines play a role in
sae-mediated virulence factor production or contribute to staphylococcal virulence.
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Introduction
Staphylococcus aureus is an important human pathogen that causes
a wide variety of diseases, ranging from minor skin infections to
life-threatening blood infections, endocarditis, pneumonia, and
toxic shock syndrome [1,2]. The bacterial pathogen can infect
almost every part of the human body and this versatility of the
bacterium is, at least partly, due to numerous virulence factors
such as hemolysins, leukocidins, and immune modulators. The
expression of these virulence factors is coordinately regulated, for
example by multiple transcription factors or two component
systems [3]. The SaeRS two component system (TCS) in
particular plays a key role in the production of important virulence
factors such as alpha-hemolysin, coagulase, and fibronectin
binding proteins [4,5,6,7,8] in vitro and it has been shown that
SaeRS is essential for in-vivo production of alpha-hemolysin [9].
The SaeRS TCS is encoded by the saePQRS operon, in which
saeR and saeS encode the response regulator and sensor kinase,
respectively (Fig. 1A). The sae operon has two promoters, P1 and
P3 [10,11,12]. Since the P1 promoter is positively autoregulated
by the SaeRS system [11,13,14], along with alpha-hemolysin
production, P1 promoter activity and P1-driven production of
SaeP are good indicators for the function of SaeRS. In strain
Newman, a clinical isolate widely used in staphylococcal research,
SaeS has an L18P mutation in the first transmembrane domain,
which renders this sensor kinase constitutively active [10].
Recently, nonribosomally synthesized dipeptides, named aur-
eusimine A and B, were reported by Wyatt et al. to increase
staphylococcal virulence by activating the expression of virulence
genes, including those encoding alpha-hemolysin, coagulase, and
fibronectin binding proteins [15]. The dipeptides are synthesized
by the products of two genes, ausA (NWMN_0123) and ausB
(NWMN_0124) (Fig. 2A). In the report by Wyatt et al., the ausA
deletion mutant of strain Newman showed reduced hemolysis on
blood agar and attenuated virulence in a murine abscess formation
model [15]. Intriguingly, almost all (39 out of 40) virulence genes
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known to be regulated by the SaeRS TCS [15]. In particular,
activities of the hla (alpha-hemolysin) and sae P1 promoters were
severely reduced, suggesting that the SaeRS TCS is not functional
in the ausA mutant. This apparent convergence of regulons implies
that aureusimines might be the activation ligands for SaeS.
However, since the SaeS sensor kinase is constitutively active in
strain Newman [10], exactly how the ausA mutation (i.e., the
absence of the dipeptides) could abolish SaeRS-dependent
signaling is puzzling. The aim of the present study was to examine
whether the aureusimine dipeptides are the activation signals for
SaeRS. In the process of addressing this question, we found that
the original ausA mutant contains an inadvertent mutation in saeS
and, therefore, the observed involvement of aureusimines in
staphylococcal virulence was due to that mutation in saeS.
Materials and Methods
Ethics Statement
The animal study presented in this report (Approval ID: NW-
20) was approved by the Institutional Animal Care and Use
Committee at Indiana University School of Medicine-Northwest,
which complies with the guidelines of the National Institutes of
Health.
Bacterial strains, plasmids and culture conditions. The
bacterial strains used in this study are listed in Table 1.
Staphylococcus aureus cells were grown in tryptic soy broth (TSB).
For routine culture of transposon mutants, erythromycin (10 mg/
ml) was added, while chloramphenicol (5 mg/ml) was added to
cells containing the lacZ reporter plasmid pCL-P1-lacZ [16].
Generation of sae-deletion mutant (NMDsae). The sae
operon was deleted from the genome of S. aureus strain Newman
by the allelic replacement plasmid pKOR1 as reported previously
[17]. For the deletion, flanking DNA fragments (1 kb each) were
PCR-amplified from the genome with the following primers: P667
(59- GGGG ACA AGT TTGTACAAAA AAGCAGGCT G
GGGAAGTCA TTACACAAAC ACATC-39)/P668 (59- GTA
GGATCC CACAA ATTAGACATTACGTCATAATCC-39) for
saeP-flanking DNA, and P669 (59- ATA GGATCC ATTC-
ATGCTAACTCCTCATT TCTTC-39)/P670 (59-GGGGACC
ACTTTGTACAAGAAAGCTGGGT GTT ATGCAAAGTA-
ATGATATGAATCAC-39) for saeS -flanking DNA. For the
DNA amplification, the enzyme Phusion (New England Biolabs)
was used.
Chemical synthesis of aureusimine A
The synthesis of aureusimine A was adapted from the previously
reported synthesis of Phevalin 2 [18]. Details of the synthesis can
be found in Supporting Information (Fig. S1).
HPLC analysis of culture supernatants
Preparation and HPLC analysis of organic cell extracts followed
the procedures described by Wyatt et al. [15] with a few
modifications. Briefly, overnight cultures of S. aureus Newman
and the transposon mutant of ausA (WNJ-12202) were diluted
1:100 into 1 L of fresh TSB containing nalidixic acid (10 mg/ml)
and grown for 3 days on a rotary shaker (37uC, 175 rpm). The
cells and broth were extracted with 1 L of ethyl acetate twice, then
evaporated and dissolved in 1 ml of methanol. Aliquots of 0.25 ml
of the concentrated extract were analyzed by HPLC with a C18
column (Higgins Analytical Proto 200). The flow rate of the mobile
phase was 3 ml/min. Compounds were eluted using a linear
gradient from 20% to 80% acetonitrile in 0.1% TFA over 40 min.
Eluted compounds were detected by UV absorbance at 280 nm
and 322 nm. In the analysis, aureusimine A and B eluted at
19.66 min and 26.82 min, respectively.
PCR characterization of the transposon mutant. The
wild-type Newman and the transposon mutant WNJ-12202 strains
were grown in 3 ml of TSB at 37uC overnight, and chromosomal
DNAs were purified with a Zippy DNA purification kit (Zymo
Research). To detect the transposon insertion, the primers PM1
(59-TTTTAACAATTGGTGCTAGCATGC-39) and PM2 (59-
TTTATGGTA CCATTTCATTTTCCTGCTTTTTC-39) were
used. To amplify the 59 part of ausA, we used the primers PM1 and
PM3 (59-TTAGC GAGTTTAACC CAATACGC-39). The
primers were annealed to chromosomal DNA at 55uC for 15
seconds, and the DNA was amplified by the enzyme Phusion (New
England Biolabs) at 72uC for 1 min with 30 cycles.
Construction of plasmid pCL55-sae. The entire saePQRS
operon was PCR-amplified from the genome of S. aureus strain
Newman using Phusion polymerase (New England Biolabs) with
the primers: P671 (59- AAC GAATTC TTGGTACTTG-
TATTTAATCGTCTATC-39)/P783 (59-AAACTT CCGCGG
TTATGACGTAATGTCTAATTTGTG-39). The PCR product
was cut with EcoRI and ligated into the single-copy integration
plasmid pCL55 [19] cut with EcoRI and SmaI. The ligated plasmid
was transformed into Escherichia coli DH5a. To confirm that no
mutation was introduced during PCR amplification, the resulting
Figure 1. The sae locus of S. aureus (A) and saeS gene in the original ausA deletion mutant (B). A. The four open reading frames in the sae
operon are shown as open arrows with the corresponding gene names. The two sae promoters, P1 and P3, are indicated with the arrows pointing out
the transcription direction. The 83 nt duplication found in ausA deletion mutant is shown as a reversed triangle. Putative transcription terminators are
indicated by stem-loop structures. B. Chromosomal DNA was purified from the original ausA deletion mutant; then the saeRS region was PCR-
amplified and sequenced. The 83 nt duplicated in saeS is indicated by a gray-colored shadow. The start and stop codons are bold faced. For clarity,
only numbers are shown for intervening nucleotides.
doi:10.1371/journal.pone.0015703.g001
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cloned saePQRS operon.
Cell fractionation and Western blot hybridization. Cells
from an overnight culture were diluted in TSB containing
appropriate antibiotics, and grown with shaking at 37uCt ot h e
stationary growth phase (OD600=6). Allcultures were normalized by
measuring optical density (OD600=0.6). Supernatant and cells were
separated by centrifugation. Proteins in the culture supernatants were
precipitated by trichloroacetic acid (10% final concentration) on ice
for 20 min, washed with 1 ml acetone, and then air-dried. The dried
proteins were suspended in 20 ml1 6 SDS-PAGE sample buffer
(40 mM Tris HCl, pH 6.8, 2% SDS, 2 mM beta-mercaptoethanol,
4% glycerol, 0.01% bromophenol blue). Cells collected by
centrifugation were suspended in 50 ml of Tris HCl (pH 8.0); then
2 ml lysostaphin (2 mg/ml) was added. After incubation at 37uCf o r
30 min, 50 mlo f2 6 SDS-PAGE sample buffer was added. The
supernatant sample was used to detect alpha-hemolysin, whilethe cell
pelletsamplewasusedtodetectSaeP.Thesampleswereseparatedby
15% SDS-PAGE and the proteins were transferred onto a
nitrocellulose membrane (0.45 mm, Whatman). The membrane was
blocked with 10% skim milk and incubated with primary antibody
(either alpha-hemolysin antibody from rabbit or SaeP antibody from
chicken) for 1 h at room temperature; then the blot was incubated
with horseradish peroxidase (HRP)-conjugated secondary antibody
(either anti-rabbit IgG or anti-chicken IgG). Signals were detected by
a luminal enhancer solution detection kit (Thermo). The alpha-
hemolysin antibody was purchased from Sigma-Aldrich. The SaeP
antibody was generated by Genscript.
Figure 2. The ausA transposon mutant WNJ-12202 does not produce aureusimines. A. The ausAB operon in the transposon mutant WNJ-
12202. The transposon insertion is indicated by a reversed triangle. The primers (PM1, PM2, and PM3), used for PCR-amplification, are shown as
arrows. B. PCR amplification of the ausA region of wild-type Newman (W) and the transposon insertion mutant WNJ-12202 (M). The numbers at the
top represent the primer pairs. The calculated size of each product is indicated on the right of the picture. Molecular size markers are shown to the
left. C. The absence of aureusimines in the culture supernatant of the transposon mutant WNJ-12202. The culture supernatants from wild-type
Newman and the transposon mutant were extracted with ethyl acetate and suspended in methanol. The supernatant extracts were analyzed with
HPLC. As a control, synthetic aureusimine A was used. A, aureusimine A; B, aureusimine B.
doi:10.1371/journal.pone.0015703.g002
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were grown overnight and diluted in fresh media containing
chloramphenicol (5 mg/ml). The cells were further grown with
shaking at 37uC to mid-log phase (OD600=0.8). Then cells were
harvested, washed with AB buffer (60 mM K2HPO4,4 0 m M
KHPO4, 100 mM NaCl, pH 7.0), and suspended in 100 ml of the
same buffer. After 5 ml lysostaphin (2 mg/ml) was added, the cell
suspension was incubated for 15 min at 37uC and then mixed with
900 ml of AB buffer containing 0.1% (v/v) Triton X-100. The b-
galactosidase assay was performed at room temperature. As a
substrate, 4-methyl umbelliferyl b-D galactopyranoside (MUG,
Sigma) was used in the hydrolysis reaction, which was read at
366 nm excitation and 445 nm emission wavelengths.
Murine model of abscess formation. The effect of the ausA
mutation on staphylococcal virulence was examined as described
previously [20]. Briefly, after the weight of the mice was measured,
1610
7 cfu (colony forming unit) of Newman wild type and the
ausA transposon mutant WNJ-12202 were administered to 10
Balb/c mice (Harlan, USA) via retro-orbital injection. Four days
after the injection, the mice were sacrificed and their organs (heart,
kidney, liver, and spleen) were harvested. The harvested organs
were homogenized; then the cfu of bacteria in the organs was
measured using serial dilutions on TSA plates.
Antibiotic resistance test. Antibiotic resistances of the sae
deletion mutant and the wild-type Newman strains were compared
by measuring growth with Bioscreen C and EZExperiment
software (Growth Curves USA). In brief, approximately
2610
5 cfu of bacteria was inoculated into 200 ml of TSB
containing a test antibiotic and incubated for 24 h without
shaking at either 37uCo r4 3 uC. The highest concentration of the
test antibiotic was 10 mg/ml, which was serially diluted using 1:2
dilution steps. For data stability, the bacterial growth was
measured by the optical density (OD) at 420 nm–580 nm. The
presented data are the mean of quadruplicate measurements.
Environmental effects on growth. The transposon inser-
tion mutants of geh (glycerol ester hydrolase) and saeR were grown
in 3 ml TSB containing 10 mg/ml of erythromycin (TSBerm10)a t
37uC overnight. The next day, cells were collected by
centrifugation and suspended in phosphate-buffered saline (PBS)
to OD600=1. The cell suspension (500 ml) was inoculated into
500 ml TSB and incubated under various conditions (37uC vs.
43uC, +/2 erythromycin, +/2 aeration at 250 rpm). Cell growth
was determined over 24 h by measuring OD600.
Enrichment test. The transposon insertion mutants of geh
and saeR were prepared as described above. The cell suspensions
(1.5 ml each) were mixed and 500 ml of the mixed culture was
inoculated into 500 ml TSB either with or without erythromycin
(10 mg/ml). The cultures were grown at 43uC for 16 h with
shaking (250 rpm). Chromosomal DNA was purified from 1 ml of
the initial mixed culture (input) and the final cultures either with or
without erythromycin. The changes of each strain in the final
cultures were analyzed by quantitative real time PCR (qPCR)
using the following primers: gyrB-1 (59- TTGTCAGATGT-
AAACAACACGG-39), gyrB-2 (59- GTCCGTTATCCGTTAC-
TTTAATCC-39), Tn-F(59- TTTATGGTA CCATTTCATTT-
TCCTGCTTTTTC), geh-1 (59-GCAACCA TATTGTTATG
ACCACC-39), and saeR-1(59- CAACCAGTTGAACAACT-
GTCG-39). The primer pair gyrB-1/gyrB-2 was used to
normalize DNA sample loading, while the primer pairs Tn-F/
geh-1 and Tn-F/saeR-1 were used to assess changes of the geh and
saeR transposon mutants in the final cultures. The DNA
amplifications were performed with a 7900HT Fast Real Time
PCR system (Applied Biosystems) using the following conditions:
94uC 30 sec, 55uC 30 sec, 72uC 30 sec, 40 cycles. The change of
each strain was calculated with the following formula:
FoldChange~2{ CtSF{CtSI ðÞ { CtGF{CtGI ðÞ ðÞ
where CtSF = Ct of test gene (i.e. either geh or saeR) in the final
cultures; CtSI = Ct of test gene in the initial mixed culture; CtGF =
Ct of gyrB in the final cultures; CtGI = Ct of gyrB in the initial
mixed culture.
Table 1. Bacterial strains and plasmids used in this study.
Strain/Plasmid Relevant Characteristics Source
E.coli
DH5a Stratagene
S. aureus
RN4220 restriction deficient, prophage-cured [39]
Newman a clinical isolate, L18P substitution in SaeS [40]
WNJ-12202 strain Newman with the bursa aurealis transposon insertion in ausA Phoenix library
WNJ-11568 strain Newman with the bursa aurealis transposon insertion in hla Phoenix library
WNJ-9654 strain Newman with Tn917 insertion in saeP Phoenix library
NMDsae strain Newman with deletion of the sae operon This study
NewmanDausA strain Newman with ausA replaced by ermB, Em
r [15]
NM::saeR strain Newman with the bursa aurealis transposon insertion in saeR (=WNJ-01594),Em
r Phoenix library
NM::geh strain Newman with the bursa aurealis transposon insertion in geh (=WNJ-0040), Em
r Phoenix library
Plasmids
pCL55 single-copy integration plasmid, Cm
r {Lee, 1991
#978}
pCL55-sae pCL55 carrying saePQRS operon this study
pCL-P1-lacZ pCL55 carrying P1-lacZ reporter gene [16]
Em
r: resistant to erythromycin; Cm
r, resistant to chloramphenicol.
doi:10.1371/journal.pone.0015703.t001
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formula:
Enrichment Index = (Fold Change of saeR mutant)/(Fold
Change of geh mutant).
Results
The ausA transposon mutant WNJ-12202 does not
produce aureusimines
We used the ausA transposon mutant WNJ-12202 from the
phoenix library collection [21], which was kindly provided by Drs.
Olaf Schneewind and Dominique Missiakas (University of
Chicago), to test whether aureusimines are required for the
production of virulence factors. The WNJ-12202 mutant strain
has a transposon insertion 36 bp downstream of the putative ATG
start codon of ausA (Fig. 2A). To eliminate any fortuitous
mutations acquired during the mutagenesis process, the transpo-
son insertion was transduced into strain Newman with the
staphylococcal phage w85. To confirm the transposon insertion
mutation of ausA, we subjected the mutant chromosomal DNA to
PCR-amplification with the primer pairs PM1/PM2 or PM1/
PM3 (Fig. 2A). Since primer PM2 binds to the bursa aurealis
transposon sequence used for construction of the Phoenix library,
a PCR product with the primer pair PM1/PM2 can be amplified
only from genomic DNA of the transposon mutant. On the other
hand, since both PM1 and PM3 primers recognize ausA sequences,
PM1/PM3 PCR products are expected to be amplified from
genomic DNA of both the wild type and the transposon mutant
strains, but with different sizes. The size of the product amplified
from the mutant DNA is expected to be 3.2 kb larger than that
from wild-type DNA. Accordingly, using primer pairs PM1 and
PM2, and PM1 and PM3, PCR products with the expected sizes
of approximately 800 bp, or 3.8 kb, respectively, were amplified
using DNA from the transposon mutant (Fig. 2B). The latter PCR
product with a molecular weight of 3.8 kb corresponds to the sum
of the ausA (621 bp) and the transposon (3.2 kb) sequences. The
PM1/PM2 PCR product obtained from the mutant strain DNA
was sequenced, confirming the transposon insertion site (data not
shown). To verify that the ausA mutant does not produce
aureusimines, we compared the culture supernatants from the
wild-type and ausA mutant strains by organic extraction and high
performance liquid chromatography (HPLC) [15]. We chemically
synthesized aureusimine A as standard (Fig. S1). While two peaks
corresponding to aureusimines A and B were detected in the
supernatant from the wild-type strain Newman, those peaks were
not detected in the culture supernatant from the transposon
mutant (Fig. 2C), thus confirming the result of Wyatt et al. that
ausA encodes the dipeptide synthesis enzyme [15]. As expected, the
elution time of the chemically synthesized aureusimine A
corresponded to that of the first peak, interpreted as aureusimine
A. These results demonstrate that the transposon mutant WNJ-
12202 does not produce aureusimines and therefore represents an
appropriate tool for the study of the role of aureusimine
dipeptides.
SaeRS is functional in the ausA transposon mutant WNJ-
12202
Next, we tested whether the aureusimine dipeptides are
required for SaeRS signaling using the mutant strain WNJ-
12202. First, because SaeRS is critical for alpha-hemolysin
production, we examined the hemolysis pattern of the mutant
on blood agar. The tested strains were streaked against the strain
RN4220, which produces only beta-hemolysin [22]. To our
surprise, the hemolysis pattern of the ausA transposon mutant was
identical to that of wild type (see the white arrow heads in Fig. 3A),
whereas the sae deletion mutant (Dsae in Fig. 3A) showed a clear
defect in hemolysis. Furthermore, wild-type level hemolysis was
restored by insertion of the complementation plasmid pCL55-sae
[Dsae(pCL55-sae) in Fig. 3A] in the sae deletion mutant. These
results strongly indicate that ausA is not involved in controlling
expression of alpha-hemolysin, which is at variance with the results
obtained by Wyatt et al. [15].
To further test whether the ausA mutant produces alpha-
hemolysin, we used Western blot analysis. In addition, we
examined expression of SaeP, another well-known gene product
of the sae operon. Consistent with the hemolysis patterns on blood
agar, the ausA transposon mutant WNJ-12202 produced both
alpha-hemolysin and SaeP at the wild-type level (Fig. 3B),
suggesting that SaeRS signaling is intact in the ausA mutant.
When transcription from the P1 promoter of the sae operon was
examined using a P1-lacZ fusion, no significant difference was
observed between the wild type and the mutant strain (Fig. 3C),
further confirming the normal functionality of SaeRS in the ausA
transposon mutant. These data demonstrate that ausA and the
biosynthetic products of the ausA locus, the aureusimines, are not
required for SaeRS signaling.
Aureusimines do not contribute to staphylococcal
virulence
Given that our findings demonstrate that aureusimines are not
required for SaeRS signaling and SaeRS-dependent alpha-
hemolysin production, we further tested the contribution of
aureusimines to bacterial virulence. Equal numbers of cells of
the wild-type Newman and transposon mutant WNJ-12202 strains
were injected into mice; then effects on disease development were
analyzed in the same way as in the Wyatt et al. study [15].
Bacterial numbers in all tested organs were not significantly
different between mice infected with the wild-type or mutant
strains (Fig. 4). In addition, no significant difference was observed
in weight loss, showing that aureusimines are not required for
staphylococcal virulence in this murine infection model.
The original ausA deletion mutant contains an additional
mutation in saeS
Since we failed to observe a role of aureusimines in hemolysin
production or in-vivo virulence, we suspected that the original ausA
deletion mutant might have contained additional mutation(s),
especially in the saeRS genes. Therefore, we examined the saeRS
region of the original mutant used by Wyatt et al. by DNA
sequencing, which revealed that the original mutant has an 83-nt
duplication in saeS (Fig. 1). Furthermore, the hemolysis defect of
the original ausA mutant on blood agar was fully complemented by
the plasmid carrying the sae operon [DausA(pCL-sae) in Fig. 3A].
In addition, when transduced into strain Newman, the resulting
ausA deletion mutant showed the wild-type hemolysis pattern
(‘DausA, transduced’ in Fig. 3A). These results demonstrate that the
virulence defects of the ausA deletion mutant in the Wyatt et al.
study were caused by the inadvertent mutation in saeS that we
discovered.
The sae deletion mutant is more resistant to certain
antibiotics
Next, we examined whether acquisition of the additional
mutation in saeS may have resulted from conditions during
mutagenesis that selected for the mutant. Since mutagenesis often
involves growing S. aureus cells in the presence of antibiotics such as
chloramphenicol and erythromycin, if mutations in the saeRS
SaeRS Mutation Affects S. aureus Virulence
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mutants would be enriched during the mutagenesis process. We
tested this hypothesis by comparing the growth of wild-type
Newman and sae deletion mutant strains in the presence of various
antibiotics. At both 37uC and 43uC, the sae deletion mutant
showed higher resistance to chloramphenicol and erythromycin
(Fig. 5A). Although to a lesser extent, the mutant was also more
resistant to spectinomycin at 43uC and kanamycin at 37uC (data
not shown). Furthermore, because all of the antibiotics tested are
protein synthesis inhibitors, we investigated whether the sae
deletion mutant is also more resistant to other classes of antibiotics.
At 37uC, the sae-deletion mutant showed a low level of resistance
to ciprofloxacin, a DNA gyrase inhibitor (Fig. 5B). However, the
mutant was more sensitive to cell lysis caused by oxacillin, a cell-
wall synthesis inhibitor. Both wild-type and the sae deletion mutant
strains were equally sensitive to rifampicin, an RNA synthesis
inhibitor, and to tetracycline, another protein synthesis inhibitor
(data not shown). When complemented by the plasmid pCL55-sae,
the resistance to erythromycin was abolished (Fig. 5C), confirming
that increased resistance was due to the deletion of the sae operon.
A sae mutant has a growth advantage at high
temperature, aeration, and presence of erythromycin
The moderate resistance to erythromycin and chloramphenicol
stronglysuggeststhatsae mutants can be enriched during mutagenesis
when employing antibiotics. However, since in a typical mutagenesis
process (e.g., deletion or transposon insertion) the target strains
already have plasmid-conferred antibiotic resistance, the comparison
between the wild-type and sae deletion mutant strains shown in Fig. 5
might not be directly relevant to the mutagenesis process. To
examine whether sae mutants have a growth advantage and can be
enriched even with a strain that is already resistant to antibiotics, we
used two transposon mutants, NM::geh and NM::saeR. Due to the
presence of an erythromycin resistance gene in the transposon, both
strains are fully resistant to erythromycin (i.e., minimal inhibitory
concentration .100 mg/ml). NM::geh has a transposon insertion in
geh (glycerol ester hydrolase) while NM::saeR has a transposon
insertion in saeR. Since geh is already disrupted by the lysogenic phage
wNM4 [23] in strain Newman, further disruption by the transposon
insertion in geh is not expected to affect bacterial gene expression,
physiology, or virulence.
The mutants were incubated in TSB containing 10 mg/ml of
erythromycin (TSBerm10) overnight at 37uC; then equal numbers
of cells were inoculated into TSBerm10 and incubated with aeration
(250 rpm) at either 37uCo r4 3 uC. The growth advantage was
pronounced at 43uC, at which temperature NM::geh showed a
diphasic growth pattern (Fig. 6). The doubling time was 37 min for
NM::saeR while it was 113 min (4 hr–8 hr) or 44 min (9 hr–12 hr)
for NM::geh. On the other hand, at 37uC, although NM::geh
showed a little longer lag phase, the growth rate at mid-log phase
Figure 3. The SaeRS TCS is functional in the ausA transposon mutant WNJ-12202. A. Hemolysis patterns on sheep blood agar. The strains
tested were streaked against the strain RN4220, which produces only beta-hemolysin. The white arrow indicates the hemolysis caused by alpha-
hemolysin. The enhanced hemolysis at the junctions of strain RN4220 and the tested strains is due to delta-hemolysin production originating from
the test strains. NM, wild type; 12202, transposon insertion mutant WNJ-12202; Dsae, a deletion mutant of the sae operon; DausA, original ausA
deletion mutant; pCL55-sae, pCL55 plasmid containing the entire sae operon. B. Western blot analysis for alpha-hemolysis (Hla) and SaeP protein.
NM, wild type; 12202, WNJ-12202; DsaeP, a transposon insertion mutant of saeP; Dhla, a transposon insertion mutant of hla, the gene encoding
alpha-hemolysin. C. LacZ assay for P1 promoter activity. Mid-log phase cells were used to measure LacZ activity from P1-lacZ fusion in strains
Newman (NM), WNJ-12202, and the sae deletion mutant (Dsae). Bar graphs depict the mean 6 standard deviation for the relative LacZ activity of
each indicated strain.
doi:10.1371/journal.pone.0015703.g003
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NM::geh, 40.8 min). Interestingly, when we repeated the growth
test at 43uC in the absence of either erythromycin or aeration, the
pronounced growth advantage of NM::saeR over NM::geh mutant
was greatly diminished (Fig. 6, bottom panel). Without erythro-
mycin, the doubling time for NM::saeR was 30.6 min, while it was
38.9 min for NM::geh. These results suggest that high temperature,
presence of erythromycin, and aeration contribute to the growth
advantage of the sae mutant.
Sae mutants can be enriched under typical
staphylococcal mutagenesis conditions
In a typical staphylococcal mutagenesis procedure, the target
cells are incubated at 43Cu in the presence of an antibiotic and
aeration, which according to our results favors growth of sae
mutants (Fig. 6). To examine the extent of the enrichment of the
sae mutant under those growth conditions, an equal number of
NM::geh and NM::saeR cells were combined and incubated for
16 h at 43uC with aeration in the presence of erythromycin
(10 mg/ml). For comparison, we also grew the mixed cells in the
absence of erythromycin. To assess the relative ratio of the
mutants in the resulting cultures, we purified chromosomal DNA
and performed quantitative real-time PCR (qPCR), amplifying
parts of the transposon sequence, and geh or saeR. While, in the
absence of erythromycin, the NM::saeR strain was enriched
approximately 20 fold, the enrichment was increased to approx-
imately 700 fold in the presence of erythromycin (Fig. 7). These
results demonstrate that sae mutants can be enriched to a great
extent under conditions typically employed for staphylococcal
mutagenesis.
Figure 4. Aureusimines do not contribute to staphylococcal virulence. The test strains (1610
7 cfu) were administered into 10 mice per strain
via retro-orbital injection; then, four days later, after measuring weight losses, organs were harvested and bacterial cfu in the organs was determined.
In the graph, each dot represents data from one mouse. Mean and standard deviation are indicated.
doi:10.1371/journal.pone.0015703.g004
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chloramphenicol and erythromycin at 37uCo r4 3 uC. Cells were inoculated in 200 ml TSB; then the growth of the cells was measured with Bioscreen C
(Growth Curves USA) for 24 h. The antibiotics and growth temperatures are shown above each graph. The concentration (mg/ml) of antibiotics is
shown in parentheses. B. Effect of the sae deletion mutation on resistance to ciprofloxacin and oxacillin at 37uC. C. Complementation test for the sae
deletion mutant. The used erythromycin concentration is indicated to the right of the graph. pCL55, an integration vector; pCL55-sae, pCL55
containing the entire sae operon.
doi:10.1371/journal.pone.0015703.g005
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The SaeRS TCS is an important signaling system controlling
the production of multiple virulence factors and in vivo survival of
S. aureus [4,5,8]. However, how the signaling system is activated
remains unknown. Although results from the Wyatt et al. study
raised the possibility that the dipeptide aureusimines could be the
activation signal for SaeRS [15], we here demonstrate that the
results obtained by Wyatt et al., indicating an involvement of the
dipeptides in SaeRS signaling, were due to an inadvertent
mutation in saeS. We suspect that the acquisition of the saeS
mutation was facilitated by the increased resistance of sae mutants
to environmental stresses such as high temperature, aeration, and
the presence of erythromycin, the antibiotic used for the
generation of a single cross-over during the deletion of ausA [15].
The sae deletion mutant showed a moderate level of resistance
not only to erythromycin but also to chloramphenicol, another
antibiotic widely used in staphylococcal research (Fig. 5A). Both
antibiotics inhibit protein synthesis by binding to the 50S subunit
of bacterial ribosome [24,25]. Although the exact steps inhibited
by these two antibiotics are different, the binding sites of the
antibiotics overlap [25]. Therefore, it is possible that the same
change caused by the saeRS TCS mutation is responsible for the
elevated resistance to the antibiotics. However, the nature of that
change is not yet clear. One can hypothesize that some genes in
the sae regulon might be directly involved in the protein translation
Figure 6. An sae mutant has a growth advantage at high temperature, aeration, and presence of erythromycin. The transposon
mutants of saeR and geh (glycerol ester hydrolase) were grown under various conditions and the effects of three environmental factors (temperature,
the presence of erythromycin, and aeration) on the growth pattern of the mutants were examined. For clarity, only the altered environmental factor is
indicated above the graph being compared. In the test, erythromycin was added at 10 mg/ml and aeration was achieved by shaking at 250 rpm. Erm;
erythromycin.
doi:10.1371/journal.pone.0015703.g006
Figure 7. Sae mutants can be enriched under typical staphy-
lococcal mutagenesis conditions. Transposon insertion mutants of
geh (glycerol ester hydrolase) and saeR were used in this test. Equal
numbers of the two mutants were mixed and grown either in the
absence or in the presence of erythromycin (10 mg/ml) with shaking for
16 h at 43uC. Chromosomal DNA was purified from each culture and the
fold change of each strain was calculated by quantitative real time PCR
(qPCR) as described in Materials and Methods. Bar graphs indicate the
fold change of each strain. Data are presented as the mean 6 standard
deviation from three independent experiments. Input, the mixed
culture used for inoculation; - Erm, culture grown in the absence of
erythromycin; + Erm, culture grown in the presence of erythromycin.
doi:10.1371/journal.pone.0015703.g007
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Among the genes that contain SaeR-binding sequences in the
upstream region, six are involved in protein translation: peptide
chain release factor-2 (prf), 30S ribosomal proteins S20 and S21,
alanyl-tRNA synthetase, glutamyl-tRNA synthetase, and histidyl-
tRNA synthetase [16]. It remains to be determined if these or
other factors contribute to the resistance to certain antibiotics in
the saeRS mutants.
Given that the synthesis of many exoproteins is decreased in sae
mutants, it is not surprising to observe a measurable growth
advantage of the saeR mutant over the geh mutant (Fig. 6).
Intriguingly, the growth advantage of sae mutants was greatly
enhanced by the combination of three environmental stresses: high
temperature, the presence of erythromycin, and aeration. A recent
study also showed that sae mutants are 10 times more resistant to
the oxidative stresses imposed by H2O2 [26], which is known to
activate the SaeRS TCS [11]. These results raise the question of
why sae mutants are more resistant to those stresses. It is possible
that certain gene products of the sae regulon might exacerbate or
amplify the growth inhibitory effects of those stresses. However,
because not all genes belonging to the sae regulon are yet verified
experimentally, it is difficult at this point to identify candidates for
the gene products responsible for the exacerbated growth
inhibition.
Interestingly, unlike sae mutants, mutants of the agr quorum-
sensing system, another TCS important for staphylococcal
virulence, seem to be enriched in the absence of environmental
stresses [27]. In fact, due to the genetic instability of agr, global
regulatory roles have been bestowed incorrectly to several genes
such as xpr, svrA, traP, and lukSF-PV. The genetic locus xpr (more
correctly the mutation D 1058::Tn551) was identified, in a Tn551
mutagenesis, to encode a global regulator required for the
expression of lipase, alpha-toxin, delta-toxin, protease, and
nuclease [28]. However, later, all of the expression defects of the
xpr mutant were found to be caused by an additional mutation in
agrC, the gene encoding agr sensor kinase [29]. The gene svrA was
identified in a signature-tagged mutagenesis (STM) screen as a
positive regulator for agr expression because the svrA mutation
abolished expression of agr [30,31]. But the absence of agr
expression in the svrA mutant was later attributed to a frame-shift
mutation in agrC [32]. Although the traP gene was initially reported
to activate the agr system via a pathway distinct from the
autoinducing peptide (AIP) pathway [33], Adhikari et al showed
that the traP mutant contains a stop codon in agrA, the gene
encoding the response regulator, which, in turn, explains the lack
of agr activity in the traP mutant [22]. Finally, a PVL phage strain
of S. aureus producing Panton-Valentine Leukocidin (PVL), a pore-
forming toxin encoded by lukSF-PV, was reported to exhibit an agr-
negative phenotype (i.e., reduced expression of multiple exopro-
teins and enhanced expression of surface proteins such as SdrD
and Spa) [34]. However, Villaruz et al. demonstrated that the PVL
phage strain used in the original study carried a point mutation at
the AgrA binding site in agr P2 promoter; therefore, the agr-
negative phenotype of the PVL phage strain was caused by the
point mutation in the agr P2 promoter, not by expression of PVL
[35]. Together with our report on the saeS mutation in the ausA
mutant, these examples clearly show that great care should be
taken during genetic manipulation of S. aureus in order to prevent
acquisition of secondary mutations, especially in saeRS and agr, and
appropriate genetic complementation experiments used.
Currently, the use of antibiotics during mutagenesis of
staphylococcal genes is inevitable. Since sae mutants show elevated
resistance to chloramphenicol, erythromycin, and, to a lesser
extent, kanamycin, spectinomycin, and ciprofloxacin, when one of
these antibiotics is used, it would be prudent to confirm that the
resulting mutant does not contain an inadvertent mutation in the
sae operon. For confirmation, a convenient method is using a
hemolysis assay on blood agar. In particular, if the test strain is
streaked on sheep blood agar against RN4220 as shown in Fig. 3A
[22], the enhancement of b-hemolysis by delta-hemolysin at the
strain junction can also reveal the functionality of the agr quorum-
sensing system. This is of particular importance because agr
mutants can arise spontaneously in the laboratory as well as in
clinical settings [22,27,29,32,35,36,37,38]. Since the sae mutants
do not seem to be more resistant to tetracycline, if a choice is
given, usage of tetracycline can minimize the enrichment of sae
mutants.
Since our results showed that aureusimines do not play a role in
sae-mediated virulence factor production or virulence in animal
models, it remains to be determined what roles these dipeptides
play in S. aureus. Intriguingly, the upstream sequence of ausA
contains an imperfect SaeR binding sequence (ATTAA-
GAATTTGTTAA), indicating that the expression of ausAB genes
might be regulated by saeRS TCS [16]. Certainly, more work is
required to identify the role(s) of these dipeptides in S. aureus.
Supporting Information
Figure S1 Chemical synthesis of aureusimine A. For each
step, reagents and reaction conditions are presented with yields.
DCC, N,N’-Dicyclohexylcarbodiimide; HOBT, Hydroxybenzo-
triazole; DIPEA, Diisopropylethylamine; DIBAL, Diisobutylalu-
minium hydride; THF, tetrahydrofuran; DCM, dimethylene
chloride; TEA, triethylamine; RT, room temperature.
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